Reports: Pfizer and Moderna allege ‘declining vaccine efficacy’ to push booster shot
The first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore receives an injection. (University of Maryland School of Medicine via AP)
OAN Newsroom
UPDATED 3:23 PM PT – Monday, July 12, 2021
COVID-19 vaccine manufacturers have stirred up speculation of declining vaccine efficiency in efforts to promote booster shots. In a series of statements, Pfizer and Moderna claimed real-world data has shown their vaccine efficiency fell short of 90 percent, especially in older patients.
As a result, the two companies suggested fully vaccinated individuals would need a third shot or a “booster.” However, both the Centers for Disease Control and Prevention and U.S. Federal Drug Administration announced a booster shot was not needed at this time.
Americans who have been fully vaccinated against #COVID19 do not need a booster shot at this time. FDA, CDC, and NIH are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary. Read full CDC/FDA statement. https://t.co/njQ4dLv8dW
— CDC (@CDCgov) July 9, 2021
Analysts stated COVID-19 has become a lucrative business model for Pfizer and Moderna, who may lose revenue if the virus went away.
“We’re talking about vaccinating literally millions and millions of people who are of absolutely no risk from COVID-19,” asserted Dr. Marcus de Brun of Rush Family Practice. “This is the first time I’ve ever encountered in my medical career and I think in the history of human medicine where we’re vaccinating people who don’t need to be vaccinated.”
Meanwhile, Pfizer is reportedly requesting an FDA authorization to roll out a booster shot, but officials remain skeptical.